Lawrence@Innoplexus

20 years of experience in the life science space as a Leader of P&Ls and Teams. Aiming to disrupt the way companies use data to take decision.

[Lawrence@Innoplexus @GantiLawrence]

Read my latest article explaining why #pharma #innovation will most likely revolve around #AI and #blockchain. https://t.co/DaGejc0nSe

[Lawrence@Innoplexus @GantiLawrence]

Read my latest article explaining how #blockchain can increase #collaboration by allowing #pharma researchers to share insights with one another in a secure and open way. https://t.co/hIcLqsLaJs

[Lawrence@Innoplexus @GantiLawrence]

Read my latest article explaining how #pharma companies can remain competitive and profitable by using #AI and #blockchain to develop niche and rare #diseases. https://t.co/c7Gi7UrtCG

[Lawrence@Innoplexus @GantiLawrence]

Read my latest article to learn a few ways that #blockchain can make the jobs of #pharma #researchers easier. https://t.co/URul6PJJKY

[POLITICO @politico]

Drug shortages are not a new problem, but low prices and industry consolidation have squeezed supplies https://t.co/JBIZlgzAbz

[Peter Loftus @Loftus]

Drugmakers continue price increases: Aytu BioScience recently bought rights to a spray form of Ambien and then raised the price as much as 843% https://t.co/dOzbUzv0TM via @WSJ

[Lawrence@Innoplexus @GantiLawrence]

Read my latest piece explaining why #pharma companies create duplicative work and how #AI and #blockchain can help. https://t.co/wmbx2mPWCZ

[Lawrence@Innoplexus @GantiLawrence]

My latest piece at @pharmaphorum: Four steps #pharma companies can take to build a dynamic culture of #innovation https://t.co/r8aBZD8fTe

[Innoplexus @Innoplexus]

Meet Gaurav Tripathi, Co-Founder and CTO, at #AI and #Blockchain Strategies Summit discussing the future of AI & blockchain reducing drug costs and accelerating the speed of drug discovery:

https://t.co/GI3C8jsmCZ

[Lawrence@Innoplexus @GantiLawrence]

My latest piece at Internet Health Management: why #pharma marketers should move beyond KOLs to true #KeyInfluencers. https://t.co/FKAHtqJIJc

[Lawrence@Innoplexus @GantiLawrence]

At the #SLA2018 conference in Baltimore. Sharing how we can inspire creative insights for information management professionals. #innoplexus.

[Innoplexus @Innoplexus]

10 days to go #AIsummit: Gunjan Bhardwaj, @Innoplexus "We need people who can translate business problems into #datascience and understand the fundamentals of #AI. That's why we actively shape the #AI-ecosystem in Frankfurt." Be part of it June 18.
https://t.co/5l7MWFTZEG

[AiThority.com @AiThority]

How AI And Blockchain Can Revolutionize Pharmaceutical Trials https://t.co/ri4gs75aVw @Innoplexus @Gunjan_GB #AInews

[Innoplexus @Innoplexus]

Attending #SLA2018? Meet us at booth 626 to find out how artificial intelligence is revolutionizing pharma with @GantiLawrence https://t.co/FiWhbz6xdM

#artificialintelligence #blockchain #bigdata #datascience #healthsciences

[Lawrence@Innoplexus @GantiLawrence]

My latest piece @pharmaphorum explores how pharma companies can drive innovation by sharing their failures: https://t.co/doK3dnJoGo #pharma #drugdiscovery #transparency

[pharmaphorum @pharmaphorum]

To unlock #innovation #pharma needs to be honest about failure. Read more about how this is a lesson the pharmaceutical industry would do well to learn in Lawrence Ganti's, CEO Americas @Innoplexus article

[Lawrence@Innoplexus @GantiLawrence]

Incentivizing failure in drug development. Our new platform facilitates scientists to share their failure so others can learn...and if others gain, our blockchain allows the originating scientist to receive credit. Now that is democratizing drug development! https://t.co/HWuZbnj4wb

[Innoplexus @Innoplexus]

We are happy to announce our upcoming product relaunch of new #iPlexus. Starting end of June it will combine #blockchain and #ai to resolve inefficiencies in early-stage drug discovery.

#research #science #drugdiscovery

https://t.co/frEuVGOe6m

[Lawrence@Innoplexus @GantiLawrence]

@Innoplexus Incentivizing failure in drug development. Our new platform facilitates scientists to share their failure so others can learn...and if others gain, our blockchain allows the originating scientist to receive credit. Now that is democratizing drug development!

[Innoplexus @Innoplexus]

@Innoplexus is looking forward to John McGovern Award Lecture, and Janet Doe Lecture at #mlanet18. #iPlexus Academic gives you detailed information on major international and national congresses out there.
https://t.co/uQBhggluKr
#healthcare #AI #medlibs #mlanet18

[Lawrence@Innoplexus @GantiLawrence]

Excited to share the results of our new study, which dives into consumers' views of transparency, #drugpricing, and other issues within #pharma. Take a look here! https://t.co/mgWbsmAi0J